Top Markets
#1 0G 0G +41.72%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.19%
#3 Useless Coin Useless Coin +36.56%
#4 Arbitrum Arbitrum +30.16%
#5 SAFEcoin SAFEcoin +29.17%
#6 StonkBroker StonkBroker +27.88%
#7 Pons Pons +22.11%
#8 Notcoin Notcoin +21.42%
#9 Zora Zora +18.97%
#10 Full Moon Full Moon +18.20%
Coin of the day
0G 0G
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Rangering i aksjer #13829
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Aksjekurs
$4.36
Markedsverdi
$457.32M
Endring (1 dag)
0.69%
Endring (1 år)
289.29%
Land
US
Handel Relmada Therapeutics, Inc. (RLMD)

Kategori

Healthcare
Antall utestående aksjer for Relmada Therapeutics, Inc. (RLMD)
Antall utestående aksjer per August 2026: 0
Ifølge Relmada Therapeutics, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Relmada Therapeutics, Inc. (RLMD) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH